XML 170 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 947 $ 1,040 $ 2,939 $ 3,128
Cost of products sold 439 471 1,329 1,385
Gross profit 508 569 1,610 1,743
Selling, general, and administrative expenses 401 395 1,187 1,174
Research and development expenses 41 39 131 122
Goodwill impairment 1,187 0 1,187 0
Intangible asset impairment and other costs 97 3 107 11
Operating (loss) income (1,218) 132 (1,002) 436
Other income and expenses:        
Interest expense, net 14 14 41 43
Other expense (income), net 9 5 20 4
(Loss) income before income taxes (1,241) 113 (1,063) 389
(Benefit) provision for income taxes (164) 29 (128) 97
Net (loss) income (1,077) 84 (935) 292
Less: Net income attributable to noncontrolling interest 0 0 0 0
Net (loss) income attributable to Dentsply Sirona $ (1,077) $ 84 $ (935) $ 292
Net (loss) income per common share attributable to Dentsply Sirona:        
Basic (in dollars per share) $ (5.01) $ 0.39 $ (4.34) $ 1.34
Diluted (in dollars per share) $ (5.01) $ 0.38 $ (4.34) $ 1.32
Weighted average common shares outstanding:        
Basic (in shares) 214.9 218.6 215.6 218.6
Diluted (in shares) 214.9 220.5 215.6 220.7